products of the Plaintiff sold under the brand "ULTRAMOL" are
paracetamol preparations in different dosage forms. The grievance of the
Plaintiff ... ULTRAMOL" in different dosage forms of the
same medicine, i.e., paracetamol.
CS(COMM) 240/2022 Page 1 of 19
Signature Not Verified
Digitally
case relates to the
pharmaceutical preparation containing 'ibuprufen' and 'paracetamol'. The
Plaintiff claims rights in the mark 'COMBIFLAM', which ... plaintiff launched its
product COMBIFLAM PLUS tablets, a formulation of
paracetamol and caffeine. In 2014, the plaintiff applied
for registration of 'COMBIFLAM
doctors for
treating COVID-19 patients like Favipiravir,
Tociluzumab, Enoxaparin, Ivermectin,
Methylprednisolone, Paracetamol and Hydroxy-
chloroquine are being priced at exorbitant rates
creating issues ... production and supply of drugs such
as Favipiravir, Enoxaparin, Ivermectin,
Methylprednisolone, Paracetamol and Hydroxy-
chloroquine. The supply of Remdesivir and Tociluzumab
is already under
with
respect to a combination of 'Ibuprofen' and 'Paracetamol' tablets.
4. It is averred that the Defendants in the present case
with
respect to a combination of 'Ibuprofen' and 'Paracetamol' tablets.
4. It is averred that the Defendants in the present case
